Invesco's stock fell 5.13% and hit a 5-day low amid broader market gains, with the Nasdaq-100 up 0.80% and the S&P 500 up 0.38%.
Invesco reported a Q4 non-GAAP EPS of $0.62, exceeding expectations by $0.04, which underscores the company's robust profitability and enhances market confidence. The company achieved $1.26 billion in revenue for Q4, reflecting an 8.6% year-over-year increase and surpassing market expectations by $10 million. Additionally, net long-term inflows reached $19.1 billion, primarily driven by ETFs and index funds, showcasing investor confidence in the company's offerings.
Despite the positive earnings report, Invesco's stock price declined, indicating a potential sector rotation as investors may be reallocating funds to other sectors amid the overall market strength.
Wall Street analysts forecast IVZ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IVZ is 28.68 USD with a low forecast of 25.00 USD and a high forecast of 33.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Analyst Rating
Wall Street analysts forecast IVZ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IVZ is 28.68 USD with a low forecast of 25.00 USD and a high forecast of 33.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
7 Hold
0 Sell
Moderate Buy
Current: 27.560
Low
25.00
Averages
28.68
High
33.50
Current: 27.560
Low
25.00
Averages
28.68
High
33.50
Goldman Sachs
Neutral
maintain
2026-01-28
New
Reason
Goldman Sachs
Price Target
AI Analysis
2026-01-28
New
maintain
Neutral
Reason
Goldman Sachs raised the firm's price target on Invesco to $29.50 from $28.75 and keeps a Neutral rating on the shares.
TD Cowen
Buy
maintain
2026-01-28
New
Reason
TD Cowen
Price Target
2026-01-28
New
maintain
Buy
Reason
TD Cowen raised the firm's price target on Invesco to $34.50 from $33.50 and keeps a Buy rating on the shares. The firm updated its model following better than expected Q4 results and Cowen raised its estimates above consensus on its expanding operating leverage.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for IVZ
Unlock Now
BofA
Neutral
downgrade
$29 -> $28
2026-01-28
New
Reason
BofA
Price Target
$29 -> $28
2026-01-28
New
downgrade
Neutral
Reason
BofA lowered the firm's price target on Invesco to $28 from $29 and keeps a Neutral rating on the shares. Following the Q4 report, the firm reduced its Q1, 2026, 2027 and 2028 EPS estimates "slightly," driven primarily by higher third-party distribution, service and fees related to QQQ.
Argus
Stephen Biggar
Buy
maintain
$27 -> $31
2026-01-28
New
Reason
Argus
Stephen Biggar
Price Target
$27 -> $31
2026-01-28
New
maintain
Buy
Reason
Argus analyst Stephen Biggar raised the firm's price target on Invesco to $31 from $27 and keeps a Buy rating on the shares after its Q4 earnings beat. Net long-term inflows were still healthy at $19.1B and have been positive for the past 10 consecutive quarters, with the company also having continued to show margin expansion, the analyst tells investors in a research note.
About IVZ
Invesco Ltd. is an independent investment management firm. It serves the retail and institutional markets within the investment management industry in the Americas, Europe, Middle East, and Africa and Asia-Pacific in 120 countries. It offers a range of investment strategies across asset classes, investment styles, and geographies. Its asset classes include equity, fixed income, balanced, alternatives and money market. Its retail assets under management include exchange-traded funds, separately managed accounts, individual savings accounts, investment companies with variable capital, investment trusts, open-end mutual funds, unit investment trusts, and variable insurance funds. Its institutional assets include institutional separate accounts, private funds, open-end mutual funds, and collective trust funds. Its client base includes public and private entities, unions, non-profit organizations, endowments, foundations, financial institutions, and sovereign wealth funds.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
